Brandi Giovanni, Deserti Marzia, Vasuri Francesco, Farioli Andrea, Degiovanni Alessio, Palloni Andrea, Frega Giorgio, Barbera Maria A, de Lorenzo Stefania, Garajova Ingrid, Di Marco Mariacristina, Pinna Antonio D, Cescon Matteo, Cucchetti Alessandro, Ercolani Giorgio, D'Errico-Grigioni Antonietta, Pantaleo Maria A, Biasco Guido, Tavolari Simona
Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi University Hospital, Cancer Research, University of Bologna, Bologna, Italy.
Department of Experimental, Diagnostic, and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, Italy.
Oncologist. 2016 Dec;21(12):e5-e6. doi: 10.1634/theoncologist.2016-0286. Epub 2016 Nov 2.
Brandi et al. clarify data about the localization of human equilibrative nucleoside transporter 1 in cancer patients receiving gemcitabine-based chemotherapy. They discuss methodology, differences between antibodies, and recommendations for further study.
布兰迪等人阐明了接受吉西他滨化疗的癌症患者中人类平衡核苷转运体1的定位数据。他们讨论了方法、抗体之间的差异以及进一步研究的建议。